LANXESS successfully places EUR 500 million benchmark bond

NOT FOR DISTRIBUTION, PUBLICATION OR FORWARDING, DIRECTLY OR INDIRECTLY, TO OR IN THE U.S., CANADA, AUSTRALIA, JAPAN OR OTHER COUNTRIES IN WHICH SUCH PUBLICATION COULD BE UNLAWFUL
Cologne
The specialty chemicals company LANXESS has successfully placed a 6-year-tenor euro benchmark bond with a coupon of 0.0 percent in the European capital market. LANXESS will use the funds to finance the planned acquisition of the microbial control business of US-based chemical company IFF.

The new bond is listed on the Luxembourg Stock Exchange in denominations of EUR 1,000.

“We have secured a first step of financing already quickly after the announcement of the deal and are happy about the very receptive reaction of the capital market to our offering,” said LANXESS CFO Michael Pontzen.

LANXESS' issuer ratings are currently Baa2 (Moody’s), BBB (Standard & Poor’s) and BBB+ (Scope). A bank consortium of active joint bookrunners comprising Citi, Société Générale and Unicredit was mandated to place the bond.

Information for editors:
All LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com. Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.

You can find further information concerning LANXESS chemistry at http://lanxess.com/en/Media/Stories.

MORE ABOUT THIS TOPIC

INVESTOR NEWS

LANXESS confirms guidance despite subdued start to the year

May 07, 2026
INVESTOR NEWS

LANXESS once again leads the European Dow Jones Best-in-Class Index

May 01, 2026
INVESTOR NEWS

LANXESS expects business to pick up in the second half of 2026 at the earliest

March 19, 2026
INVESTOR NEWS

LANXESS: Moody’s rating change with limited impact on financing costs

March 09, 2026
INVESTOR NEWS

LANXESS: Update on ENVALIOR Stake

March 05, 2026